Literature DB >> 2320126

Imprinting of acetylcholine receptor messenger RNA accumulation in mammalian neuromuscular synapses.

H R Brenner1, V Witzemann, B Sakmann.   

Abstract

IN mammalian muscle, the subunit composition of the nicotinic acetylcholine receptor (AChR) and the distribution of AChRs along the fibre are developmentally regulated. In fetal muscle, AChRs are distributed over the entire fibre length whereas in adult fibres they are concentrated at the end-plate. We have used in situ hybridization techniques to measure the development of the synaptic localization of the messenger RNAs (mRNAs) encoding the alpha-subunit and the epsilon-subunit of the rat muscle AChR. The alpha-subunit is present in both fetal and adult muscle, whereas the epsilon-subunit appears postnatally and specifies the mature AChR subtype. The synaptic localization of alpha-subunit mRNA in adult fibres may arise from the selective down-regulation of constitutively expressed mRNA from extrasynaptic fibre segments. In contrast, epsilon-subunit mRNA appears locally at the site of neuromuscular contact and its accumulation at the end-plate is not dependent on the continued presence of the nerve terminal very early during synapse formation. This suggests that epsilon-subunit mRNA expression is induced locally via a signal which is restricted to the end-plate region and is dependent on the presence of the nerve only during a short period of early neuromuscular contact. Evidently, several mechanisms operate to confine AChR mRNAs to the adult end-plate region, and the levels of alpha-subunit and epsilon-subunit mRNAs depend on these mechanisms to differing degrees.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320126     DOI: 10.1038/344544a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  58 in total

Review 1.  Target-specific expression of pre- and postsynaptic mechanisms.

Authors:  K Tóth; C J McBain
Journal:  J Physiol       Date:  2000-05-15       Impact factor: 5.182

2.  The Ets transcription factor GABP is required for postsynaptic differentiation in vivo.

Authors:  A Briguet; M A Ruegg
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

3.  Small-conductance calcium-activated potassium currents in mouse hyperexcitable denervated skeletal muscle.

Authors:  T R Neelands; P S Herson; D Jacobson; J P Adelman; J Maylie
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

4.  Sodium channel mRNAs at the neuromuscular junction: distinct patterns of accumulation and effects of muscle activity.

Authors:  S S Awad; R N Lightowlers; C Young; Z M Chrzanowska-Lightowlers; T Lomo; C R Slater
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

5.  The 5'-flanking region of the mouse muscle nicotinic acetylcholine receptor beta subunit gene promotes expression in cultured muscle cells and is activated by MRF4, myogenin and myoD.

Authors:  C A Prody; J P Merlie
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

6.  Perinuclear localization of slow troponin C m RNA in muscle cells is controlled by a cis-element located at its 3' untranslated region.

Authors:  Kishore K Reddy; Ferry M Oitomen; Gopal P Patel; Jnanankur Bag
Journal:  RNA       Date:  2005-03       Impact factor: 4.942

7.  Ion channels: this year's Nobel prize in physiology or medicine.

Authors:  D Colquhoun
Journal:  BMJ       Date:  1991-10-19

8.  A novel synapse-associated noncoding RNA.

Authors:  M A Velleca; M C Wallace; J P Merlie
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

Review 9.  Control of receptor sensitivity at the mRNA level.

Authors:  B J Morris
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

10.  Acetylcholine receptor epsilon-subunit deletion causes muscle weakness and atrophy in juvenile and adult mice.

Authors:  V Witzemann; H Schwarz; M Koenen; C Berberich; A Villarroel; A Wernig; H R Brenner; B Sakmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.